MARKET

NPCE

NPCE

Neuropace Inc
NASDAQ
1.720
-0.110
-6.01%
After Hours: 1.720 0 0.00% 16:56 12/07 EST
OPEN
1.790
PREV CLOSE
1.830
HIGH
1.990
LOW
1.630
VOLUME
30.04K
TURNOVER
0
52 WEEK HIGH
12.06
52 WEEK LOW
1.380
MARKET CAP
42.83M
P/E (TTM)
-0.9020
1D
5D
1M
3M
1Y
5Y
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
MOUNTAIN VIEW, Calif., November 30, 2022--NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that the first patient with Lennox-Gastaut Syndrome (LGS) ...
Business Wire · 11/30 13:00
$10 Million Bet On Canoo? Check Out These 3 Stocks Under $3 Insiders Are Buying
Benzinga · 11/25 14:43
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11/24 21:31
NeuroPace Files $150 Million Mixed Shelf
NeuroPace Files $150 Million Mixed Shelf
MT Newswires · 11/09 03:57
BRIEF-NeuroPace Reports Third Quarter 2022 Financial Results, Provides A Business Update
Reuters · 11/08 23:11
NeuroPace Sees FY22 Revenue Of $44.5M-$45.5M Compared To Previous Expectation Of $43M-$45M
Benzinga · 11/08 22:02
BRIEF-Neuropace Inc Files For Mixed Shelf Of Up To $150 Mln
Reuters · 11/08 22:00
NeuroPace Q3 EPS $(0.48) Beats $(0.53) Estimate, Sales $11.16M Beat $9.89M Estimate
Benzinga · 11/08 22:00
More
About NPCE
NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

Webull offers kinds of Neuropace Inc stock information, including NASDAQ:NPCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NPCE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NPCE stock methods without spending real money on the virtual paper trading platform.